G
Giselle Mosnaim
Researcher at NorthShore University HealthSystem
Publications - 103
Citations - 1812
Giselle Mosnaim is an academic researcher from NorthShore University HealthSystem. The author has contributed to research in topics: Asthma & Medicine. The author has an hindex of 18, co-authored 73 publications receiving 1050 citations. Previous affiliations of Giselle Mosnaim include Rosalind Franklin University of Medicine and Science & Rush University Medical Center.
Papers
More filters
Journal ArticleDOI
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic.
Marcus Shaker,Marcus Shaker,John Oppenheimer,Mitchell H. Grayson,David R. Stukus,Nicholas Hartog,Elena W Y Hsieh,Nicholas L. Rider,Cullen M. Dutmer,Timothy K. Vander Leek,Harold Kim,Edmond S. Chan,Doug Mack,Anne K. Ellis,David M. Lang,Jay A. Lieberman,David Fleischer,David B.K. Golden,Dana Wallace,Jay M. Portnoy,Giselle Mosnaim,Matthew Greenhawt +21 more
TL;DR: An expert panel consensus document offers a prioritization rational to help guide decision making when such situations arise and an allergist/immunologist is forced to reduce services or makes the decision on his or her own to do so.
Journal ArticleDOI
Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist.
Priya Bansal,Theresa Bingemann,Matthew Greenhawt,Giselle Mosnaim,Anil Nanda,John Oppenheimer,Hemant Sharma,David R. Stukus,Marcus Shaker +8 more
TL;DR: Understanding the stressors that COVID-19 is placing on clinicians can assist in recognizing what is needed to return to a point of wellness, and implementing wellness strategies can improve flexibility, resilience, and outlook.
Journal ArticleDOI
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.
Matthew Greenhawt,Elissa M. Abrams,Marcus Shaker,Derek K. Chu,David A. Khan,Cem Akin,Waleed Alqurashi,Peter D. Arkwright,James L. Baldwin,Moshe Ben-Shoshan,Jonathan A. Bernstein,Theresa Bingemann,Katharina Blumchen,Aideen Byrne,Antonio Bognanni,Dianne E. Campbell,Ronna L. Campbell,Zain Chagla,Edmond S. Chan,Jeffrey Chan,Pasquale Comberiati,Timothy E. Dribin,Anne K. Ellis,David Fleischer,Adam T. Fox,Pamela A. Frischmeyer-Guerrerio,Remi Gagnon,Mitchell H. Grayson,Caroline C. Horner,Jonathan Hourihane,Constance H. Katelaris,Harold Kim,John M. Kelso,David M. Lang,Dennis K. Ledford,Michael Levin,Jay A. Lieberman,Richard Loh,Doug Mack,Bruce Mazer,Giselle Mosnaim,Daniel Munblit,S. Shahzad Mustafa,Anil Nanda,John Oppenheimer,Kirsten P Perrett,Allison Ramsey,Matthew A. Rank,Kara Robertson,Javed Sheikh,Jonathan M. Spergel,David R. Stukus,Mimi L.K. Tang,James M. Tracy,Paul Turner,Anna Whalen-Browne,Dana Wallace,Julie Wang,Susan Waserman,John K. Witry,Margitta Worm,Timothy K. Vander Leek,David B.K. Golden +62 more
TL;DR: In this article, a multidisciplinary group of international experts in anaphylaxis composed of allergy, infectious disease, emergency medicine, and front-line clinicians to systematically develop recommendations regarding SARS-CoV-2 vaccine immediate allergic reactions.
Journal ArticleDOI
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
David Sullivan,Kelly A. Gebo,Shmuel Shoham,Evan M. Bloch,Bryan Lau,Aarthi Shenoy,Giselle Mosnaim,Thomas J. Gniadek,Yuriko Fukuta,Bela Patel,Sonya L. Heath,Adam C. Levine,Barry Meisenberg,Emily S Spivak,Shweta Anjan,Moises A. Huaman,R. E. Blair,Judith S. Currier,James H. Paxton,Jonathan M. Gerber,Joann Petrini,Patrick B Broderick,W P Rausch,Marie Elena Cordisco,Jean M Hammel,B. Greenblatt,Valerie Cluzet,Daniel L. Cruser,Kevin Oei,M. S. Abinante,Laura L. Hammitt,Catherine G. Sutcliffe,Donald N. Forthal,Martin S. Zand,Edward R. Cachay,Jay S. Raval,Seble Kassaye,E C Foster,Michael Roth,Christi E. Marshall,Anusha Yarava,Karen Lane,Nichol McBee,Amy L. Gawad,Nicky Karlen,Atika Singh,Daniel E. Ford,Douglas A. Jabs,Lawrence J. Appel,David M. Shade,Stephan Ehrhardt,Sheriza N. Baksh,Oliver Laeyendecker,Andrew Pekosz,Sabra L. Klein,Arturo Casadevall,Aaron A.R. Tobian,Daniel F. Hanley +57 more
TL;DR: In participants with Covid-19, most of whom were unvaccinated, the administration of convalescent plasma within 9 days after the onset of symptoms reduced the risk of disease progression leading to hospitalization.
Journal ArticleDOI